Skip to content
10-Q

Quarterly Report

KIORA PHARMACEUTICALS INC KPHMW KPRX

0001372514-25-000078

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 5, 2025 3.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.36M sh
Shares Diluted Q3 2025 · Sep 30, 2025 4.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.21M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.09M sh
Capex Q3 2025 · Sep 30, 2025 $32.63K
Capex Q3 2025 · Sep 30, 2024 $51.29K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$7.78M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $10.81M
Short Term Investments Q3 2025 · Sep 30, 2025 $13.87M
Short Term Investments Q3 2025 · Dec 31, 2024 $23M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $5.51M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $3.79M
Stockholders Equity Q3 2025 · Sep 30, 2025 $22.41M
Stockholders Equity Q3 2025 · Jun 30, 2025 $22.13M
Stockholders Equity Q3 2025 · Dec 31, 2024 $25.76M
Stockholders Equity Q3 2025 · Sep 30, 2024 $30.03M
Stockholders Equity Q3 2025 · Jun 30, 2024 $33.1M
Stockholders Equity Q3 2025 · Dec 31, 2023 $6.11M
Current Liabilities Q3 2025 · Sep 30, 2025 $2.58M
Current Liabilities Q3 2025 · Dec 31, 2024 $6.01M
Total Liabilities Q3 2025 · Sep 30, 2025 $7.45M
Total Liabilities Q3 2025 · Dec 31, 2024 $10.72M
Current Assets Q3 2025 · Sep 30, 2025 $22.69M
Current Assets Q3 2025 · Dec 31, 2024 $29.71M
Total Assets Q3 2025 · Sep 30, 2025 $29.86M
Total Assets Q3 2025 · Dec 31, 2024 $36.48M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.01
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.04
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.81
Eps Diluted Q3 2025 · Sep 30, 2024 $1.91
Eps Basic Q3 2025 · Sep 30, 2025 $0.01
Eps Basic Q3 2025 · Sep 30, 2025 −$1.04
Eps Basic Q3 2025 · Sep 30, 2024 −$0.81
Eps Basic Q3 2025 · Sep 30, 2024 $2.08
Sga Expense Q3 2025 · Sep 30, 2025 $1.44M
Sga Expense Q3 2025 · Sep 30, 2025 $4.29M
Sga Expense Q3 2025 · Sep 30, 2024 $1.38M
Sga Expense Q3 2025 · Sep 30, 2024 $4.22M
Rd Expense Q3 2025 · Sep 30, 2025 $2.73M
Rd Expense Q3 2025 · Sep 30, 2025 $7.85M
Rd Expense restated Q3 2025 · Sep 30, 2024 $2.18M
Rd Expense restated Q3 2025 · Sep 30, 2024 $5.92M
Net Income Q3 2025 · Sep 30, 2025 $26.81K
Net Income Q3 2025 · Sep 30, 2025 −$4.32M
Net Income Q3 2025 · Sep 30, 2024 −$3.41M
Net Income Q3 2025 · Sep 30, 2024 $7.82M
Operating Income Q3 2025 · Sep 30, 2025 −$794.44K
Operating Income Q3 2025 · Sep 30, 2025 −$5.52M
Operating Income Q3 2025 · Sep 30, 2024 −$3.6M
Operating Income Q3 2025 · Sep 30, 2024 $7.07M